Advertisement
Screener

OSR HEALTH, INC. (OSRH) Increase (Decrease) in Other Current Assets

OSR HEALTH, INC. Increase (Decrease) in Other Current Assets

OSR HEALTH, INC. (OSRH) reported Increase (Decrease) in Other Current Assets of $73.86 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2026-08-14

  • OSR HEALTH, INC. increase (decrease) in other current assets for the quarter ending 2026-06-30 was $67.64K.
  • OSR HEALTH, INC. increase (decrease) in other current assets for the quarter ending 2026-03-31 was $6.22K, a 46.40% decline year-over-year.
  • OSR HEALTH, INC. increase (decrease) in other current assets for the quarter ending 2025-12-31 was -$320.44K, a 6948.41% decline year-over-year.
  • OSR HEALTH, INC. increase (decrease) in other current assets for the quarter ending 2025-09-30 was -$21.62K.
  • OSR HEALTH, INC. increase (decrease) in other current assets for fiscal 2025 was -$350.64K, a 2367.35% decline from fiscal 2024.
  • OSR HEALTH, INC. increase (decrease) in other current assets for fiscal 2024 was $15.46K.
Period endIncrease (Decrease) in Other Current Assets 3 monthIncrease (Decrease) in Other Current Assets 3 month as first filedIncrease (Decrease) in Other Current Assets 6 monthIncrease (Decrease) in Other Current Assets 9 monthIncrease (Decrease) in Other Current Assets 12 month
2026-06-30$67.64K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14
$73.86K
10-Q · filed 2026-08-14
-$246.58K
derived: sum of 3 quarters · filed 2026-08-14
-$268.20K
derived: sum of 4 quarters · filed 2026-08-14
2026-03-31$6.22K
10-Q · filed 2026-05-13
-$314.22K
derived: sum of 2 quarters · filed 2026-05-13
-$335.84K
derived: sum of 3 quarters · filed 2026-05-13
-$356.03K
derived: sum of 4 quarters · filed 2026-08-14
2025-12-31-$320.44K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
-$342.06K
derived: sum of 2 quarters · filed 2026-03-31
-$362.24K
derived: sum of 3 quarters · filed 2026-08-14
-$350.64K
10-K · filed 2026-03-31
2025-09-30-$21.62K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
-$41.81K
derived: sum of 2 quarters · filed 2026-08-14
-$30.21K
10-Q · filed 2025-11-12
-$25.53K
derived: sum of 4 quarters · filed 2026-08-14
2025-06-30-$20.18K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14
-$8.59K
10-Q · filed 2026-08-14
-$3.91K
derived: sum of 3 quarters · filed 2026-08-14
-$146.31K
derived: sum of 4 quarters · filed 2026-08-14
2025-03-31$11.60K
10-Q · filed 2026-05-13
$11.60K
10-Q · filed 2025-05-20
$16.28K
derived: sum of 2 quarters · filed 2026-05-13
-$126.12K
derived: sum of 3 quarters · filed 2026-05-13
-$10.68K
derived: sum of 4 quarters · filed 2026-05-13
2024-12-31$4.68K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
-$137.72K
derived: sum of 2 quarters · filed 2026-03-31
-$22.27K
derived: sum of 3 quarters · filed 2026-03-31
$15.46K
10-K · filed 2026-03-31
2024-09-30-$142.40K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
-$26.95K
derived: sum of 2 quarters · filed 2025-11-12
$10.79K
10-Q · filed 2025-11-12
2024-06-30$115.44K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14
$153.18K
10-Q · filed 2025-08-14
2024-03-31$37.74K
10-Q · filed 2025-05-20

Similar stocks

Stock NameCountryMarket CapPE Ratio
Adagio Medical Holdings, Inc. (ADGM)United States$0.004B
Autonomix Medical, Inc. (AMIX)United States$0.004B
Bluejay Diagnostics, Inc. (BJDX)United States$0.004B
AETHLON MEDICAL INC (AEMD)United States$0.005B
Beyond Air, Inc. (XAIR)United States$0.003B-0.01
Vivos Therapeutics, Inc. (VVOS)United States$0.003B-0.26
INTELLIGENT BIO SOLUTIONS INC. (INBS)United States$0.005B
NEXGEL, INC. (NXGL)United States$0.002B
INVO Fertility, Inc. (IVF)United States$0.002B-0.71
Sonoma Pharmaceuticals, Inc. (SNOA)United States$0.006B-2.59